Publicações

Sequential Therapies After Atezolizumab plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

AuthID
P-00Z-GG2

Author(s)

Persano, M

Rimini, M

Tada, T

Suda, G

Shimose, S

Kudo, M

Cheon, J

Finkelmeier, F

Presa, J

Masi, G

Yoo, C

Lonardi, S

Piscaglia, F

Iavarone, MA

Tamburini, E

Cabibbo, G

Silletta, M

Cascinu, S

Scartozzi, M

Gardini, AC

Document Type

Abstract

Year published

2023

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 34, Pages: S603-S604 (2)

Conference

Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: OCT 20-24, 2023, Location: Barcelona, SPAIN

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2023.09.2117

Wos: WOS:001087480201303

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Sequential Therapies After Atezolizumab plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

Useful Links

Get Help

Autenticação Federada (Click on the image)

Sequential Therapies After Atezolizumab plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

Useful Links

Get Help